Yeswe can assess glutathione status through functional lab testing, along with markers for liver function, oxidative stress, and detox capacity
Patients interested in participating should speak with their GP or specialist, who can advise on eligibility and refer to appropriate research centres
in misuse scenarios, cardiomegaly has been reported
Treatment recommendations vary based on provider evaluation and individual goals
What was considered cutting-edge just a few years ago is now standard practice, and the tools available to researchers are becoming exponentially more sophisticated
Starting mid-2026, Medicare will cover injectable weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound for eligible individuals with severe obesity or related health conditions, at a cost of $245 per month to Medicare and a maximum $50 monthly copay for recipients